课题基金 / 基金详情

Genetics of Beta Cell Failure in Mexican Americans

Genetics of Beta Cell Failure in Mexican Americans
墨西哥裔美国人β细胞衰竭的遗传学
批准号:
6698090
负责人:
Thomas A Buchanan
金额:
$137.93万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-20 至 2007-12-31

项目摘要

项目成果

Thomas A Buchanan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In young Hispanic women who developed gestational diabetes mellitus (GDM) during pregnancy, we have identified relatively early-onset and progressive loss of insulin secretion that precedes and predicts the development of type 2 diabetes mellitus (T2DM). The defect in insulin secretion appears to be caused or worsened by insulin resistance and it is highly heritable in families of GDM probands. Based on these observations, we hypothesize that there are genetic determinants of the defect in insulin secretion that leads to T2DM in these young women. We have extensive experience with the performance of detailed phenotyping to quantify insulin secretion and insulin resistance in large cohorts of Hispanic Americans, including one large family-based cohort. We also have access to a large number of large families with a GDM proband. Accordingly, we propose to search for genetic determinants of the beta-cell defect that we have identified, using detailed phenotyping combined with candidate gene and genome-wide QTL linkage analysis. The present application is focused on the recruitment and phenotyping of Mexican American women with GDM and their siblings and first cousins (i.e., families enriched with the B-cell defect) and of matched control women who maintained normal glucose tolerance during pregnancy (robust B-cell function). All of these individuals will have detailed studies of B-cell function, insulin sensitivity and body composition. Additional family members will provide DNA for assessment of identity-by-descent and for future construction of haplotypes in GDM probands and matched controls. Studies of selected candidate genes for GDM and T2DM will be conducted during this award period. Support for a genome-wide scan will be sought separately and will be followed by fine mapping and association studies of positional candidate regions and genes. Ultimately, the results of this project will be crucial in attaining our long-term goals of (a) understanding the fundamental cause(s) of T2DM in young Hispanic Americans and (b) developing strategies to predict and prevent that disease at relatively early stages in its evolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Southern California Clinical and Translational Science Institute
  • 批准号:
    10700623
  • 项目类别:
  • 资助金额:
    $4.99万
  • 财政年份:
    2023
  • 负责人:
    Thomas A Buchanan
  • 依托单位:
Southern California Clinical and Translational Science Institute
  • 批准号:
    10559463
  • 项目类别:
  • 资助金额:
    $900.97万
  • 财政年份:
    2016
  • 负责人:
    Thomas A Buchanan
  • 依托单位:
Southern California Clinical and Translational Institute
  • 批准号:
    9929249
  • 项目类别:
  • 资助金额:
    $53.47万
  • 财政年份:
    2016
  • 负责人:
    Thomas A Buchanan
  • 依托单位:
Southern California Clinical and Translational Science Institute
  • 批准号:
    10613592
  • 项目类别:
  • 资助金额:
    $919.29万
  • 财政年份:
    2016
  • 负责人:
    Thomas A Buchanan
  • 依托单位:
国内基金
海外基金
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孙贤杰
  • 依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
  • 批准号:
    82303919
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    陈鹭跃
  • 依托单位: